Denmark Ranks Among the Top 20 Countries in the World for Per Capita Pharmaceutical Spending, at Around US$492 in 2004

Research and Markets (http://www.researchandmarkets.com/reports/c10098) has announced the addition of Denmark Pharmaceutical Country Intelligence Report to their offering

(PRWEB) November 27, 2004 -- The main features of the current, decentralised, healthcare system have been in place since the late 1970s. Prior to the election of the liberal-conservative government in 2001, healthcare development had been incremental, with operational changes largely resulting from previous government cost containment policies. These changes were aimed towards the rationalisation of the hospital system and a primary healthcare based organisational structure.

Whatever your needs, whether you are monitoring developments in national markets, identifying new opportunities, assessing product areas, or using the data as an integral part of your market planning, WPM's country reports are invaluable. Sections are included on the organisation and administration of health services, healthcare expenditure, hospital and outpatient services, medical personnel and healthcare development. Issues relevant to the pharmaceutical market environment are outlined, including regulation, registration, patent protection and distribution. The market section includes data on domestic production and international trade.

1.Introduction

2.Background

3.Population

4.Health Status

5.Health Expenditure

6.Organisation & Administration

7.Hospital Services

8. Outpatient Care

9.Medical Personnel

10.Healthcare Development

11.Pharmaceutical Market Environment

12.Pharmaceutical Market

13.International trade

14.Directory

For more information visit http://www.researchandmarkets.com/reports/c10098

Laura Wood

Senior Manager

Research and Markets

press@researchandmarkets.com

Fax: +353 1 4100 980

###